Advanced Biomed Inc. (NASDAQ:ADVB – Get Free Report) was the target of a large decrease in short interest in the month of August. As of August 14th, there was short interest totaling 37,364 shares, a decrease of 34.7% from the July 30th total of 57,213 shares. Currently, 3.1% of the company’s shares are sold short. Based on an average daily volume of 231,612 shares, the days-to-cover ratio is presently 0.2 days.
Advanced Biomed Trading Up 12.0%
Advanced Biomed stock traded up $1.13 during trading on Tuesday, hitting $10.58. The company had a trading volume of 281,463 shares, compared to its average volume of 885,909. The stock has a market cap of $17.46 million, a price-to-earnings ratio of 2.20 and a beta of -0.41. Advanced Biomed has a 1-year low of $3.61 and a 1-year high of $24.23. The company’s 50 day simple moving average is $7.77 and its 200-day simple moving average is $5.85.
Analysts Set New Price Targets
ADVB has been the subject of a number of recent analyst reports. Weiss Ratings raised Advanced Biomed from a “sell (e+)” rating to a “sell (d-)” rating in a research report on Thursday, July 23rd. Wall Street Zen raised shares of Advanced Biomed to a “hold” rating in a research note on Saturday, August 22nd. One analyst has rated the stock with a Sell rating, Based on data from MarketBeat.com, the company has a consensus rating of “Sell”.
About Advanced Biomed
Our Mission We are committed to the application research of integrating semiconductor technology and biotechnology. Through the enrichment, capture, and identification of circulating tumor cells and related tumor marker cells in the field of liquid biopsy, we aim to provide cancer patients with rapid and affordable assay products and services. These services include early screening and detection, diagnosis and staging, treatment selection, and patient outcome interventions for cancer. We are a holding company incorporated in the State of Nevada.
Featured Stories
- Five stocks we like better than Advanced Biomed
- Dutch Bros Sell-Off Creates a Growth Opportunity
- NVIDIA’s MediaTek Bet Shows How It Plans to Defend Its AI Moat
- Is Abercrombie & Fitch’s Hot Streak Just Getting Started?
- Medtronic’s Stars Are Aligning for a Price Recovery
Receive News & Ratings for Advanced Biomed Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Advanced Biomed and related companies with MarketBeat.com's FREE daily email newsletter.
